Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Epsilon Healthcare Limited ( (AU:EPN) ) has provided an update.
Epsilon Healthcare Limited reported a 19% increase in revenue to $3.4 million for the half-year ending June 2025, driven by new client engagements and the successful launch of Epsilon Pharmacy. Despite the revenue growth, the company experienced a net loss of $2.07 million, attributed to administrative fees, interest, and loan charges, as well as costs associated with remediation work due to voluntary administration.
The most recent analyst rating on (AU:EPN) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Epsilon Healthcare Limited stock, see the AU:EPN Stock Forecast page.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited operates in the healthcare industry, focusing on building client engagements and consolidating existing client relationships. The company has introduced a new business segment, Epsilon Pharmacy, which has exceeded revenue expectations.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.21M
Learn more about EPN stock on TipRanks’ Stock Analysis page.